Physician profile
James Maxwell
NPI 1932137213
$26,999.94
in general payments reported to CMS, 2019-2025
9 companies · $94.19 in 2025
The $94.19 reported for 2025 was less than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $16K · 2020: $3,781 · 2021: $6,032 · 2022: $297 · 2023: $750 · 2024: $155 · 2025: $94.19.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $998.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $998.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $18,165.51 | 2019-2020 | |
| Medtronic, INC. | $6,650.30 | 2021-2023 | Avalus, Mosaic |
| Abbott Laboratories | $1,607.70 | 2019-2023 | Thoratec Heartmate 3 Lvas Implant Kit |
| Ethicon US, LLC | $135.87 | 2023 | Prolene |
| Baxter Healthcare | $131.10 | 2024 | Perclot, Floseal |
| Edwards Lifesciences Corporation | $108.49 | 2022-2025 | Hemosphere |
| Getinge USA Sales, LLC | $92.19 | 2021-2025 | Vasoview Hemopro 2 |
| Intuitive Surgical, INC. | $74.78 | 2021 | |
| Abiomed | $34.00 | 2023 | Impella |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Maxwell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.